Now showing items 1-2 of 2
Next-Generation Antimalarial Drugs: Hybrid Molecules as a New Strategy in Drug Design
(Department of Infectious Diseases, Hamamatsu University School of Medicine, Hamamatsu, Japan. 2 Centre for Biotechnology Research and Development, Kenya Medical Research Institute (KEMRI) Nairobi, Kenya),, 2010)
Malaria is a disease that affects nearly 40% of the global population, and chemotherapy remains the mainstay of its control strategy. The global malaria situation is increasingly being exacerbated by the emergence of ...